United States-based medical devices and health care company Abbott (NYSE: ABT) announced on Friday that its board of directors declared a quarterly common dividend of USD0.59 per share.
This represents the 405th consecutive quarterly dividend since 1924. Payment is scheduled for 15 May 2025, to shareholders of record as of 15 April 2025.
Abbott has raised its dividend for 53 consecutive years. Inclusion in the S&P 500 Dividend Aristocrats Index reflects its commitment to annual dividend increases for over 25 years.
Saluda Medical secures CE certification for EVA Sensing Technology in Europe
Antin to acquire clinical trial equipment provider Emsere
Hyphens Pharma licenses Cerapro skin cream to Louis Widmer for six European markets
Profusa signs French distributor to expand Lumee Oxygen rollout in Europe
Sensiva Health names new chief operating officer
BrioHealth Solutions enrols 100th participant in BrioVAD System trial
Abbott's Amplatzer Piccolo Delivery System receives US FDA clearance and CE Mark
Amphix Bio announces initial closing of USD12.5m seed financing round
Bioretec wins FDA breakthrough status for biodegradable orthopaedic DrillPin
Amferia raises EUR3.5m to advance antimicrobial wound-care platform
BioCryst wins FDA approval for oral HAE prophylaxis in young children
ALR Technologies announces GluCurve Pet CGM relaunch in Canada
Galderma secures EU MDR certification for Sculptra, expanding use to multiple body areas
Clinical Laserthermia Systems applies for CE marking of ClearPoint Prism neuro laser system